Eiichi Tahara

868 total citations
17 papers, 729 citations indexed

About

Eiichi Tahara is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Eiichi Tahara has authored 17 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Eiichi Tahara's work include Cancer-related Molecular Pathways (7 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Research and Treatments (4 papers). Eiichi Tahara is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Research and Treatments (4 papers). Eiichi Tahara collaborates with scholars based in Japan, United States and United Kingdom. Eiichi Tahara's co-authors include Hiroshi Yokozaki, Wataru Yasui, Kazuhito Naka, Takenori Ishikawa, Hidetoshi Tahara, Wataru Yasui, Hiroki Kuniyasu, Ken Hayashi, E Tahara and Shigehiro Ono and has published in prestigious journals such as Journal of neurosurgery, International Journal of Cancer and Cancer Letters.

In The Last Decade

Eiichi Tahara

17 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiichi Tahara Japan 14 441 304 165 106 92 17 729
Ira Kogan Israel 8 410 0.9× 309 1.0× 75 0.5× 135 1.3× 28 0.3× 9 656
R. F. Newbold United Kingdom 12 533 1.2× 157 0.5× 329 2.0× 97 0.9× 31 0.3× 18 760
Shin-Geon Choi United States 6 508 1.2× 117 0.4× 87 0.5× 72 0.7× 42 0.5× 9 694
Antonio Díaz‐López Spain 13 375 0.9× 272 0.9× 86 0.5× 302 2.8× 29 0.3× 15 682
M. Wick Germany 10 444 1.0× 243 0.8× 210 1.3× 159 1.5× 41 0.4× 12 857
Takayuki Kodama Japan 11 367 0.8× 161 0.5× 502 3.0× 82 0.8× 86 0.9× 26 846
Gregg Magrane United States 10 325 0.7× 182 0.6× 69 0.4× 87 0.8× 39 0.4× 15 578
Oksana I. Dukhanina United States 7 517 1.2× 393 1.3× 64 0.4× 91 0.9× 13 0.1× 13 779
Brian T. Zafonte United States 10 325 0.7× 125 0.4× 57 0.3× 54 0.5× 87 0.9× 13 538
Hilda Martinez-Diaz United States 4 621 1.4× 253 0.8× 31 0.2× 138 1.3× 34 0.4× 4 755

Countries citing papers authored by Eiichi Tahara

Since Specialization
Citations

This map shows the geographic impact of Eiichi Tahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Tahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Tahara more than expected).

Fields of papers citing papers by Eiichi Tahara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiichi Tahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Tahara. The network helps show where Eiichi Tahara may publish in the future.

Co-authorship network of co-authors of Eiichi Tahara

This figure shows the co-authorship network connecting the top 25 collaborators of Eiichi Tahara. A scholar is included among the top collaborators of Eiichi Tahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiichi Tahara. Eiichi Tahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Taniyama, Kiyomi, Steve Goodison, Reiko Ito, et al.. (2001). PTEN expression is maintained in sporadic colorectal tumours. The Journal of Pathology. 194(3). 341–348. 28 indexed citations
2.
Yokozaki, Hiroshi, Hiroki Kuniyasu, Ken Hayashi, et al.. (2000). Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines. International Journal of Cancer. 88(6). 992–997. 113 indexed citations
3.
Harada, Kunyu, et al.. (2000). Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker. Journal of neurosurgery. 93(4). 618–625. 37 indexed citations
4.
Hayashi, Ken, Hiroshi Yokozaki, Kazuhito Naka, et al.. (2000). Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines. Cancer Letters. 151(2). 199–208. 28 indexed citations
5.
Harada, Kunyu, et al.. (2000). Growth Inhibition of Human Glioma Cells by Transfection-induced P21 and its Effects on Telomerase Activity. Journal of Neuro-Oncology. 47(1). 39–46. 22 indexed citations
6.
Yasui, Wataru, et al.. (1999). Expression of the E2F family in human gastrointestinal carcinomas. International Journal of Cancer. 81(4). 535–538. 94 indexed citations
7.
Nakamura, Yasuhiro, et al.. (1999). Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Molecular Carcinogenesis. 26(4). 312–320. 42 indexed citations
8.
Tahara, Eiichi. (1998). Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection. Experimental and Toxicologic Pathology. 50(4-6). 375–378. 22 indexed citations
9.
Akama, Yoshihiko, Hiroshi Yokozaki, Shuho Semba, et al.. (1997). Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. Pathology International. 47(7). 470–477. 33 indexed citations
10.
Yasui, Wataru, Hiroshi Yokozaki, & Eiichi Tahara. (1997). Molecular Diagnosis of Gastrointestinal Cancer. PubMed. 25(2). 187–207. 4 indexed citations
12.
Sugino, Takashi, Kazuhiro Yoshida, John Bolodeoku, et al.. (1996). Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates. International Journal of Cancer. 69(4). 301–306. 104 indexed citations
13.
Frieß, Helmut, Yoichiro Yamanaka, Markus W. Büchler, et al.. (1994). Cripto, a member of the epidermal growth factor family, is over‐expressed in human pancreatic cancer and chronic pancreatitis. International Journal of Cancer. 56(5). 668–674. 76 indexed citations
14.
Ayhan, A., Wataru Yasui, Hiroshi Yokozaki, et al.. (1994). Loss of Heterozygosity at the bcl‐2 Gene Locus and Expression of bcl‐2 in Human Gastric and Colorectal Carcinomas. Japanese Journal of Cancer Research. 85(6). 584–591. 46 indexed citations
15.
Yoshida, Kazuhiro, Hiroki Kuniyasu, Wataru Yasui, et al.. (1993). Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor ?. Journal of Cancer Research and Clinical Oncology. 119(7). 401–407. 46 indexed citations
16.
Yasui, Wataru, Kazuhiro Yoshida, Hiroshi Yokozaki, et al.. (1991). Inhibitory Effect of 8‐Chloro‐cyclic Adenosine 3′,5′‐Monophosphate on Cell Growth of Gastric Carcinoma Cell Lines. Japanese Journal of Cancer Research. 82(3). 325–331. 13 indexed citations
17.
Tsuda, Toshitaka, Hiroshi Nakatani, Eiichi Tahara, et al.. (1989). <italic>HST</italic>1 and <italic>INT</italic>2 Gene Coamplification in a Squamous Cell Carcinoma of the Gallbladder. Japanese Journal of Clinical Oncology. 19(1). 26–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026